Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 10(1): 194, 2019 01 14.
Article in English | MEDLINE | ID: mdl-30643127

ABSTRACT

Repurposed CRISPR-Cas molecules provide a useful tool set for broad applications of genomic editing and regulation of gene expression in prokaryotes and eukaryotes. Recent discovery of phage-derived proteins, anti-CRISPRs, which serve to abrogate natural CRISPR anti-phage activity, potentially expands the ability to build synthetic CRISPR-mediated circuits. Here, we characterize a panel of anti-CRISPR molecules for expanded applications to counteract CRISPR-mediated gene activation and repression of reporter and endogenous genes in various cell types. We demonstrate that cells pre-engineered with anti-CRISPR molecules become resistant to gene editing, thus providing a means to generate "write-protected" cells that prevent future gene editing. We further show that anti-CRISPRs can be used to control CRISPR-based gene regulation circuits, including implementation of a pulse generator circuit in mammalian cells. Our work suggests that anti-CRISPR proteins should serve as widely applicable tools for synthetic systems regulating the behavior of eukaryotic cells.


Subject(s)
Bacteriophages/genetics , CRISPR-Cas Systems/genetics , Gene Editing/methods , Gene Regulatory Networks/genetics , Cell Culture Techniques , Clustered Regularly Interspaced Short Palindromic Repeats/genetics , Eukaryotic Cells , Genetic Vectors/genetics , HEK293 Cells , Humans , Induced Pluripotent Stem Cells , Intravital Microscopy/methods , Lentivirus/genetics , Microscopy, Fluorescence/methods , Time-Lapse Imaging/methods , Transduction, Genetic/methods , Transfection/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...